sym-trinitrobenzene has been researched along with Neuroblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berthold, F; Bohlen, H; Diehl, V; Leenen, C; Manzke, O; Russello, O | 1 |
1 other study(ies) available for sym-trinitrobenzene and Neuroblastoma
Article | Year |
---|---|
Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; CD3 Complex; Gangliosides; Haptens; Humans; Immunotherapy; Immunotoxins; Mice; Mice, SCID; Neuroblastoma; Ricin; T-Lymphocytes, Cytotoxic; Trinitrobenzenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |